Page 28 - Generative Ai News Today

Bill Gates' latest book recommendation focuses on the future of artificial intelligence and AI. Here's why the Microsoft co-founder wants you to read it.

Gridspace is a wonderful case study of a speech technology company on the bleeding edge of Machine Learning and Generative AI. You will learn how the founders managed to bootstrap to large paying customers and then raise strategic funding. You will also learn the nuances of how they used various Open Source components and existing ML models to get to a point where they can afford to develop more original technology. You will also learn the importance of solutions versus technology platforms. Sr...

With growing corporate use of generative artificial intelligence, hallucinations and code errors don't top the list of company concerns. Data leaks are No. 1.

Divya Pratap Mehta, Founder of Intertwined Brand Solutions guides planners through AI's power in shaping marketing.

​Now, we are in a phase today where we are close to, of course, election, markets have rallied before. So, clearly one has to be cautious but this is not a time to be sitting on cash because we really do not know what the event is going to throw up.

​In each bull market, there will be pockets of exuberance, but there will be some other pockets which will be out of favour and that is where we tend to look for opportunities.

Austin-based EdTech startup, LearnWith.AI, launched TeachTap, a groundbreaking mobile app that harnesses the power of Generative AI to transform the way high school students learn and prepare for Advanced Placement (AP) exams.

The selected organisations will focus on areas like climate, economic opportunities, health, education, and crisis response

Generative AI is a recently developed type of artificial intelligence capable of producing new and original content such as text, images, videos, and audio. It accomplishes tasks by learning statistical patterns from existing data, then using those patterns to generate new outputs upon request.

It won't be long for artificial intelligence can handle drug discovery for pharmaceutical companies without human scientists.